Healthcare combines pharmaceuticals, biotech, medical devices, care providers, health insurers, and health-information services. It is home to names like Eli Lilly, UnitedHealth, Johnson & Johnson, and Merck. The sector blends growth and defensive traits — demand for treatment and medicine stays relatively steady across cycles, with strong innovation catalysts in drugs and gene therapy. On this page we rank the best US healthcare stocks by the EL7 Score and compare them across value, growth, quality, safety, and capital-return factors.
4 of 11
P/E 25.2 vs period average 24.4 Richer than its history
Ranked among 258 stocks with a market cap above $2B. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/258 | ![]() | $266.30 | 40.3 | 99 | 2 | 100 | 100 |
| 2/258 | ![]() | $10.20 | 12.1 | 93 | 97 | 91 | 100 |
| 3/258 | ![]() | $31.68 | 3.3 | 89 | 82 | 98 | 99 |
| 4/258 | ![]() | $113.31 | 14.4 | 87 | 77 | 96 | 99 |
| 5/258 | ![]() | $65.11 | 20.5 | 71 | 74 | 97 | 99 |
| 6/258 | ![]() | $36.83 | 12.0 | 94 | 70 | 96 | 98 |
| 7/258 | ![]() | $17.04 | 7.4 | 85 | 85 | 91 | 98 |
| 8/258 | ![]() | $1279.14 | 42.9 | 29 | 90 | 92 | 98 |
| 9/258 | ![]() | $145.87 | 21.4 | 72 | 88 | 95 | 98 |
| 10/258 | ![]() | $869.33 | 21.5 | 51 | 100 | 98 | 98 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $11B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $22B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $4B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.1% | $47B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
The white line marks the average score (70.4) · the number beside the score is the stock count
Upgrades and downgrades on the sector's stocks
يحتل قطاع الرعاية الصحية المرتبة الرابعة بدرجة 76.22، مدعوماً بجودة تشغيلية متينة وزخم سعري قوي، رغم أن تقييماته تبدو مرتفعة حالياً مع وسيط مكرر ربحية يبلغ 25.17. يجمع القطاع بين الأمان المالي والعوائد الرأسمالية الجيدة، وتبرز فيه أسهم مثل JNJ وHLN كأفضل الخيارات أداءً وفقاً لمعايير التصنيف.